2013
DOI: 10.1021/jm301607v
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of a Class of Novel Tankyrase Inhibitors that Bind to Both the Nicotinamide Pocket and the Induced Pocket

Abstract: Potent and selective inhibitors of tankyrases have recently been characterized to bind to an induced pocket. Here we report the identification of a novel potent and selective tankyrase inhibitor that binds to both the nicotinamide pocket and the induced pocket. The crystal structure of human TNKS1 in complex with this "dual-binder" provides a molecular basis for their strong and specific interactions and suggests clues for the further development of tankyrase inhibitors.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
48
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 41 publications
(49 citation statements)
references
References 16 publications
1
48
0
Order By: Relevance
“…18,19 Also dual binders interacting with both of the subsites have recently been developed. 20,21 The hit compounds identified in this study bind to the NI subsite similarly to several other previously characterized ARTD inhibitors, such as 1 (XAV939). We utilized the available structural data in structure-based virtual screening approach with an aim to identify new tankyrase inhibitor scaffolds.…”
Section: Introductionmentioning
confidence: 76%
“…18,19 Also dual binders interacting with both of the subsites have recently been developed. 20,21 The hit compounds identified in this study bind to the NI subsite similarly to several other previously characterized ARTD inhibitors, such as 1 (XAV939). We utilized the available structural data in structure-based virtual screening approach with an aim to identify new tankyrase inhibitor scaffolds.…”
Section: Introductionmentioning
confidence: 76%
“…Highly selective and potent inhibitors of TNKS (TNKSi) have been developed and characterized in different cancer models (8,(13)(14)(15)(16)(17), including colorectal cancer in which constitutive Wnt activity is a major driver of tumor maintenance (18,19). However, inhibition of TNKS is not sufficient to fully suppress Wnt signaling, resulting in only partial tumor growth inhibition (15).…”
Section: Introductionmentioning
confidence: 99%
“…21−23 Very recently, some quinazolin-4-ones carrying (CH 2 ) 2 CONHAr at position-2 have been reported as binding both to the nicotinamide-binding site and at an induced pocket. 24 A crystal structure of 1 bound into the nicotinamide-binding region of the catalytic domain of TNKS-2 was published in 2010, 25 Figure 1.…”
mentioning
confidence: 99%